Exposure to an environmentally relevant mixture of brominated flame retardants affects fetal development in Sprague-Dawley rats  by Berger, Robert G. et al.
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Brominated  ﬂame  retardants  are  incorporated  into  a wide  variety  of  consumer  products  and  are  known
to enter  into  the  surrounding  environment,  leading  to  human  exposure.  There  is accumulating  evidence
that  these  compounds  have  adverse  effects  on  reproduction  and  development  in humans  and  animal
models.  Animal  studies  have  generally  characterized  the outcome  of  exposure  to  a  single  technical  mix-
ture or  congener.  Here,  we determined  the  impact  of exposure  of  rats  prior  to mating  and during  gestation
to  a  mixture  representative  of congener  levels  found  in North  American  household  dust.  Adult  female
Sprague-Dawley  rats  were  fed  a diet  containing  0,  0.75,  250  or 750  mg/kg  of  a  mixture  of ﬂame  retardants
(polybrominated  diphenyl  ethers,  hexabromocyclododecane)  from  two  weeks  prior to  mating  to  gesta-
tion day  20. This  formulation  delivered  nominal  doses  of  0, 0.06,  20 and  60 mg/kg  body  weight/day.  The
lowest  dose approximates  high  human  exposures  based  on  house  dust  levels  and  the  dust  ingestion  rates
of toddlers.  Litter  size  and  resorption  sites  were  counted  and  fetal  development  evaluated.  No  effects  on
maternal  health,  litter  size,  fetal  viability,  weights,  crown  rump  lengths  or sex ratios  were  detected.  The
proportion  of  litters  with  fetuses  with  anomalies  of  the  digits  (soft  tissue  syndactyly  or malposition  of  the
distal  phalanges)  was  increased  signiﬁcantly  in  the low  (0.06  mg/kg/day)  dose  group.  Skeletal  analysis
revealed  a decreased  ossiﬁcation  of the sixth  sternebra  at all  exposure  levels.  Thus,  exposure  to  an  envi-
ronmentally  relevant  mixture  of brominated  ﬂame  retardants  results  in  developmental  abnormalities  in
the  absence  of apparent  maternal  toxicity.  The  relevance  of  these  ﬁndings  for predicting  human  risk  is
yet to be  determined.
rs.  Pu©  2014  The  Autho
. Introduction
Brominated ﬂame retardants (BFRs) are incorporated into a
ide variety of household and commercial goods to reduce ﬂame
ropagation and ignition rates (Camino et al., 1991). Many BFRs do
ot form covalent bonds with the polymer matrices in products to
hich they are added and leach out into the environment. Recently,
 major class of BFRs, the polybrominated diphenyl ethers (PBDEs),
ere withdrawn from commerce in North America and Europe
Abbreviations: BFRs, brominated ﬂame retardants; PBDEs, polybrominated
iphenyl ethers; HBCD, hexabromocyclododecane.
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300-483X/© 2014 The Authors. Published by Elsevier Ireland Ltd. T
http://creativecommons.org/licenses/by-nc-nd/3.0/).blished  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
due to their environmental persistence and bioaccumulative prop-
erties (EC, 2011; Tullo, 2003). Despite this, products containing
PBDEs, such as furniture or electronic devices, continue to be used
(Stapleton et al., 2012). In spite of their being banned in North
America, analyses of house dust show that BFRs are present in the
majority of North American homes; PBDEs and hexabromocyclodo-
decane (HBCD) are prominent among the BFRs that are detected
(Allen et al., 2008; Stapleton et al., 2008) and have not declined
appreciably since being removed from commerce (Dodson et al.,
2012); recent studies demonstrate that BFRs are still found in the
serum of pregnant women (Zota et al., 2013).
Brominated ﬂame retardants are detected in various human
tissues, with the highest concentrations detected in North Amer-
icans (Hites, 2004; Sjödin et al., 2004; Toms et al., 2009). Primary
routes of exposure have been identiﬁed as inhalation and inges-
tion of dust (Johnson et al., 2010; Stapleton et al., 2005; Wu et al.,
2007) and dietary consumption (Fraser et al., 2009; Wu  et al., 2007).
his is an open access article under the CC BY-NC-ND license
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ecent investigations have shown that BFRs are detected in serum
Johnson et al., 2010; Meeker et al., 2009), hair (Aleksa et al., 2012),
dipose tissue (Johnson-Restrepo et al., 2005), breast milk and ovar-
an follicular ﬂuid (Johnson et al., 2012; Petro et al., 2012; Marchitti
t al., 2013). Children have the highest serum BFR concentrations,
ith peak measurements up to 2–10-fold higher than in adults
Rose et al., 2010). Increased BFR levels in infants and toddlers may
e a result of additional exposure through hand to mouth activ-
ties (Stapleton et al., 2008, 2012) and ingestion of contaminated
reast milk (Carrizo et al., 2007; Siddique et al., 2012). Prenatal
evelopment is also vulnerable to BFR exposure through placental
ransfer (Mazdai et al., 2003). In the Montreal area, increasing lev-
ls of PBDEs were found in human fetal livers from 1998 through
006, mirroring trends in adults and children (Doucet et al., 2009).
Exposure to BFRs during in utero development is of signiﬁcant
oncern. Indeed, maternal PBDE levels during pregnancy have been
ssociated with deﬁcits in children’s attention, ﬁne motor coordi-
ation, and cognitive functioning (Eskenazi et al., 2013). PBDEs are
tructurally similar to thyroid hormone and may  disrupt thyroid
omeostasis (Darnerud et al., 2001; Ernest et al., 2012; Fowles et al.,
994; Hallgren et al., 2001; Blake et al., 2011). Alternatively, BFRs
ay  act as endocrine disruptors by altering estrogen (Ceccatelli
t al., 2006; Meerts et al., 2001) or androgen signaling (Stoker et al.,
005), or perturbing insulin-like growth factor 1 (IGF1) signaling
Haave et al., 2011; Suvorov et al., 2009; Suvorov and Takser, 2010).
n addition to their effects on the brain and developing nervous sys-
em (Dreiem et al., 2010; Saegusa et al., 2009; van der Ven et al.,
008; Ta et al., 2011), exposure to BFRs has been associated with
etrimental effects on the male and female reproductive systems
Talsness et al., 2008; van der Ven et al., 2008; Ema  et al., 2008;
ilienthal et al., 2006; Zhang et al., 2013), bone (van der Ven et al.,
009; Blanco et al., 2012), the immune system (van der Ven et al.,
009; Liu et al., 2012; Bondy et al., 2013), and the liver (Blanco et al.,
012; Ema  et al., 2008). The consequences of exposure to single BFR
ongeners, such as PBDE-47 (Talsness et al., 2008; Ta et al., 2011) or
BDE-99 (Talsness et al., 2005), or to BFR technical mixtures, such
s DE-71 (Blake et al., 2011) have been reported. For example, in
tero exposure to PBDE-99 delayed bone ossiﬁcation and enlarged
he liver (Blanco et al., 2012), decreased fertility in females (Talsness
t al., 2005), and altered steroid hormone production and the onset
f puberty (Lilienthal et al., 2006). Bone development was  altered
n animals exposed to HBCD from premating until weaning, with a
ecrease in trabecular bone mineral density of the tibia in females
van der Ven et al., 2009).
Although humans are exposed to a complex mixture of BFRs,
nimal studies have focused on the effects of a single congener or
echnical mixture. Here, we determined the effects of an environ-
entally relevant BFR mixture, typically found in household dust,
n female fertility, the establishment and maintenance of preg-
ancy, and fetal development in Sprague-Dawley rats.
. Materials and methods
.1. BFR mixture formulation
Formulation of the BFR mixture was described previously
Ernest et al., 2012). Brieﬂy, three technical PBDE mixtures (DE-71,
E-79 and BDE-209) and one HBCD mixture were combined to yield
 ratio of PBDE congeners and HBCD comparable to the median lev-
ls observed in Boston house dust (Allen et al., 2008; Stapleton et al.,
008). This BFR mixture was incorporated into an isoﬂavone-free
iet (Teklad Global 2019 diet; Harlan Laboratories, Madison, WI)
ith 4.3 g/kg corn oil. Diets were formulated to contain 0, 0.75, 250
r 750 mg  of BFR mixture/kg. Diet samples from each experimental
ondition were collected for later analysis of BFR content via gasy 320 (2014) 56–66 57
chromatography/mass spectrometry (GC/MS), as described below.
The diet formulations were intended to deliver nominal doses of
0, 0.06, 20 and 60 mg/kg body weight/day, assuming a daily food
consumption of 80 g/kg body weight/day. The lowest dose was  esti-
mated to be a close approximation of maximum human exposure,
based on a dust ingestion rate of 100 mg/day in children (16.5 kg
body weight) and the scaling of dose from humans to rodents (1:6.9,
human to rat body surface area ratio) (Allen et al., 2008; Stapleton
et al., 2008).
2.2. GC/MS analysis of dietary BFR content
Feed samples were thawed and ground to a ﬁne powder,
thoroughly mixed and weighed (∼0.1 g) into Erlenmeyer ﬂasks.
Each sample was fortiﬁed with surrogate standards (twelve 13C12
labeled PBDE congeners: 15, 28, 47, 77, 99, 100, 126, 138, 153, 154,
183, 209 and 13C12 labeled -, - and -HBCD) (Cambridge Isotope
Laboratories, Andover, MA  and Wellington Laboratories, Guelph,
ON, Canada). Distilled water (20 mL)  was added to each sample and
allowed to soak for approximately 30 min, followed by the addition
of 50 mL  acetone:hexane (2:1, v/v). Samples were homogenized for
approximately 30 s using a Silverson homogenizer. Solid material
was removed from the extract by transferring the extract to a sep-
aratory funnel through a funnel packed with glass wool. Aqueous
sodium chloride (50 mL)  was added to each separatory funnel, and
the funnel was  gently shaken and vented as necessary. Following
phase separation, the aqueous layer was  drained from the funnel,
discarded and the extract was transferred to a round bottomed ﬂask
(rbf) after passing through a bed of anhydrous sodium chloride.
Each sample was  concentrated to approximately 1 mL using rotary
evaporation and quantitatively transferred to a clean pre-weighed
vial which was  placed, uncapped, in the fume hood until a stable
weight was achieved, to allow for lipid content determination.
Samples were then re-dissolved in hexane (1–2 mL)  with gentle
swirling and added to a column containing 2% deactivated Florisil
(6 g), topped with approximately 1 cm of each of glass beads and
anhydrous sodium sulfate (Na2SO4). Once the extract was  washed
onto the column and drained to within a few millimeters of the
top of the Na2SO4, enough hexane was added to wet  the entire col-
umn  (∼5 mL). PBDEs were eluted with 70 mL  hexane and collected
in a 250 mL  rbf; the ﬂask was  then removed and retained. A sec-
ond rbf was  placed under the Florisil column and HBCD isomers
were eluted using 70 mL  dichloromethane (DCM): hexane (30:70,
v/v). Both fractions were reduced in volume to ∼1 mL  using rotary
evaporation. The PBDE extract was transferred to a v-notch vial and
evaporated to dryness using a gentle stream of nitrogen, re-diluted
in isooctane and mixed. This ﬁnal isooctane extract was transferred
to a chromatographic vial for analysis. The HBCD fraction was sim-
ilarly transferred to a v-notch vial, but taken only to near dryness
(∼50 L) using a gentle stream of nitrogen prior to the addition
of C122H18Br6 analogs of -, - and -HBCD. The samples were
then placed in a fume hood where they remained until dryness
was attained. To each dry HBCD extract, 100 L of methanol:water
(80:20, v/v) was added, the vial was mixed and the ﬁnal extract
was transferred to a chromatography vial. Dilution of feed sam-
ple extracts, to which higher levels of PBDEs and HBCD had been
added (e.g., 20 ppm, 60 ppm nominal concentrations), was neces-
sary to ensure that accurate concentration measurements could be
achieved.
PBDE analysis was  performed using an Agilent 6890 gas
chromatograph coupled to a 5973N mass selective detector (Agi-
lent, Mississauga, ON, Canada). A 15 m J&W DB5 MS (0.25 mm
i.d. × 0.10 m ﬁlm thickness) column was used for separation of the
PBDEs, following introduction of 2 L sample volumes into the cool
on-column injection system which was set to track the oven tem-
perature. The initial temperature was  set to 80 ◦C and held for 1 min,
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ncreased to 225 ◦C at a rate of 32 ◦C min−1, followed by an increase
t a rate of 3 ◦C min−1 to 230 ◦C and held for 1 min. The ﬁnal increase
as set at a rate of 40 ◦C min−1 to 315 ◦C and held for 7 min. Helium
as used as the carrier gas set at constant ﬂow (1.2 mL  min−1) for all
BDE analyses and the head pressure initially was 27 kPa. The mass
pectrometer was operating in electron impact ionization mode
nd the source temperature was 250 ◦C.
HBCD analysis was performed using an Agilent 1100 (Agilent
echnologies, Mississauga, ON, Canada) high pressure liquid chro-
atograph coupled to a Quattro Ultima triple quadrupole MS/MS
Waters Corporation, Milford, MA)  with electrospray ionization in
he negative ion detection mode using a Phenomenex Kinetex C18
olumn (2.1 mm × 150 mm,  2.6 m)  (Phenomenex, Torrance, CA).
ater (mobile phase A) and acetonitrile:methanol (2:1) (mobile
hase B) were used to separate the HBCD isomers and the gradi-
nt was as follows: 40% mobile phase B for 1 min, 40–80% phase B
or 4 min, 80–90% phase B for 13 min, then returned to 40% phase
 over 0.5 min  where it remained until 18 min. The ﬂow rate was
aintained at 0.22 mL  min−1 and the column temperature at 30 ◦C,
o completely resolve the deuterated HBCD analogs from the 13C-
abeled and native analogs. The capillary and cone voltage were
3.0 kV and 35 V, respectively. The source temperature and des-
lvation temperature were 140 ◦C and 350 ◦C, respectively. Cone
as ﬂow and desolvation gas ﬂow were 77 L h−1 and 723 L h−1,
espectively. Argon was the collision gas set at 5 × 10−3 mbar and
esolution was established at 90% valley at base for both quadrupole
nalyzers. Dwell times were set to 5 ms.
All reported sample concentrations were corrected for recover-
es using isotope dilution. Two reagent blanks, an aliquot of corn
il known to be free of PBDEs and HBCD fortiﬁed with known
oncentrations of these analytes and a reference material of ﬁsh
ertiﬁed to contain known amounts of PBDEs were included with
ach set of samples prepared for analysis. Laboratory background
as accounted for by removing the average of the PBDE and HBCD
oncentrations observed in the two reagent blank samples for each
et of samples analyzed.
Average PBDE surrogate recoveries ranged from 71% to 81%
PBDE 183 and PBDE 47, respectively) and 13C HBCD recoveries
anged from 84% to 97% (- and -HBCD, respectively) in the diet
amples. PBDE concentrations were within the expected concen-
ration range in the reference material tested and the average oil
pike recovery was 100% for PBDEs (86–109%) and 101% for HBCD
100–102%) in the fortiﬁed oil.
.3. Animals and treatment
All animal studies were conducted in accordance with the pro-
edures and principles outlined in the Guide to the Care and Use
f Experimental Animals prepared by the Canadian Council on
nimal Care (McGill Animal Research Centre protocol 5862). Vir-
in female Sprague-Dawley rats (200–250 g) were obtained from
harles River (St-Constant, QC, Canada). Animals were individu-
lly housed at the Animal Resources Centre of McGill University
n rooms maintained at 20 ◦C on a 12 h:12 h light:dark cycle. Food
nd water were provided ad libitum. Following one week of accli-
ation to the control diet, female rats were randomly assigned to
ne of four experimental conditions (n = 35–38/group) and fed a
iet supplemented with 0, 0.75, 250 or 750 mg  BFR mixture/kg for
wo to four weeks prior to mating. During this exposure period,
strus cyclicity was assessed daily by analyzing vaginal cytology,
s previously described (Goldman et al., 2007). After this premat-
ng exposure, females in proestrus were caged with proven breeder
ale Sprague-Dawley rats overnight. The next morning was  desig-
ated as gestation day (GD) 0 if spermatozoa were detected in the
aginal smear. Following insemination, females continued on theiry 320 (2014) 56–66
respective diets until euthanasia on GD 20. Throughout the pre-
mating period, dam physical examinations were undertaken and
body weight and food intake were monitored once a week. Follow-
ing mating, body weight and food intake were assessed on GDs 3,
8, 13, 16 and 20.
2.4. Tissue collection
Dams were euthanized by CO2 asphyxiation followed by exsan-
guination via cardiac puncture on GD 20. The sequence in which
dams from each treatment group were euthanized was random
and investigators were blinded as to the treatment group. Liver, kid-
neys, spleen, thymus, heart, lung, uterus and ovaries were removed
and weighed. Uterine horns were inspected for implantation and
resorption sites. The trachea, including the thyroid gland, was
removed gently and ﬁxed in neutral buffered formalin for morpho-
logical analysis. Whole blood was  transferred to a Vacutainer SST
(BD Biosciences Canada, Mississauga, ON, Canada), allowed to clot
for 30 min  at room temperature, then held on ice for no longer than
4 h until centrifugation at 1300 × g for 20 min. Serum was  aliquoted
and stored at −80 ◦C.
2.5. Thyroid gland histology
Fixed thyroid glands, in situ on the trachea, were embedded in
parafﬁn, sectioned (5 m)  and stained with periodic acid Schiff.
The height of the thyroid gland epithelium was  measured using
digital analysis in sections known to be in the interior of the gland.
Epithelial height measurements were taken from at least 5 sepa-
rate follicles per image, selected using an overlaid, numbered grid
and 5 randomly generated numbers; at least 10 images per animal
were analyzed. All measurements were made by a single observer
blinded to the animal treatment (n = 10/group).
2.6. Serum measures
Calcium, magnesium, phosphorus, blood urea nitrogen, uric
acid, albumin, total protein, creatinine kinase, creatinine, triglyc-
erides, cholesterol, glucose, alkaline phosphatase (ALP) and alanine
aminotransferase (ALT) were measured in serum with an ABX
Pentra 400 clinical chemistry analyzer (Horiba ABX, Montpellier,
France). Total serum thyroxine (T4) was  assayed using commercial
RIA kits following the manufacturer’s protocol (MP  Biomedicals,
Lachine, QC, Canada).
2.7. Fetal examinations
The position of fetuses in the uterine horns was recorded prior
to their excision from the yolk sac and separation from the pla-
centa. Placental weights and diameters were recorded. All live
fetuses were evaluated for gender, body weight, crown-rump
length and anogenital distance index (AGDI), calculated by divid-
ing the anogenital distance (mm)  by the cubed root of the body
mass (Gallavan et al., 1999). All fetuses were examined for external
physical malformations (n = 255, 365, 285 and 283 for the control,
0.06, 20 and 60 mg/kg/day BFR doses, respectively); an average of
two fetuses/litter (n = 18, 41, 26, and 38 for the control, 0.06, 20
and 60 mg/kg/day BFR doses, respectively) were prepared for the
evaluation of skeletal development. Accordingly, treatment-related
effects on external morphology were analyzed on the basis of the
proportion of litters with affected fetuses whereas skeletal evalua-
tions were based on the proportion of individual fetuses affected.Fetuses were euthanized by hypothermia prior to ﬁxation and
storage in 95% ethanol. The preparation and staining methods were
adapted from Whitaker and Dix (1979) with minor alterations.
Brieﬂy, at the time of processing, ﬁxed fetuses were immersed in
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Table  1
Dietary BFR content.
Congener (g/g) Nominal BFR mixture dose (mg/kg/day)
Control (0) 0.06 20 60
BDE-15 NDa ND ND ND
BDE-17 ND ND ND ND
BDE-28 0.0001 ± 0.00001 0.0009 ± 0.00003 0.195 ± 0.0281 0.445 ± 0.0109
BDE-37 ND ND ND ND
BDE-47 0.001 ± 0.0002 0.098 ± 0.0013 32.99 ± 3.86 100.35 ± 1.53
BDE-66 ND 0.001 ± 0.00004 0.357 ± 0.0391 1.135 ± 0.027
BDE-71  ND ND ND ND
BDE-75 ND ND ND ND
BDE-77 ND ND ND ND
BDE-85 ND 0.006 ± 0.0001 1.331 ± 0.124 3.360 ± 0.102
BDE-99 0.002 ± 0.0003 0.124 ± 0.0014 44.65 ± 4.95 136.19 ± 3.37
BDE-100 0.001 ± 0.0001 0.031 ± 0.0003 11.19 ± 1.26 32.94 ± 0.86
BDE-119  ND ND ND ND
BDE-126 ND ND ND ND
BDE-138 ND 0.002 ± 0.0004 0.475 ± 0.051 1.662 ± 0.048
BDE-153  0.003 ± 0.0015 0.011 ± 0.0002 3.62 ± 0.388 10.66 ± 0.16
BDE-154 0.001 ± 0.00001 0.011 ± 0.0002 3.78 ± 0.416 11.36 ± 0.20
BDE-160  ND ND ND ND
BDE-181 ND ND ND ND
BDE-183 ND 0.001 ± 0.00004 0.506 ± 0.0798 1.230 ± 0.051
BDE-190 ND ND ND ND
BDE-205 ND ND ND ND
BDE-209 ND 0.362 ± 0.0141 145.77 ± 11.47 361.90 ± 6.27
HBCD-  0.0009 ± 0.0003 0.018 ± 0.0003 0.304 ± 0.778 19.43 ± 0.32
HBCD-  0.0001 ± 4 × 10−6 0.001 ± 0.00005 0.381 ± 0.252 1.194 ± 0.013
HBCD- 0.0003 ± 0.0006 0.0012 ± 0.00007 0.468 ± 0.0519 1.486 ± 0.03
∑
PBDE (g/g) 0.015 ± 0.001 0.647 ± 0.033 245.68 ± 12.14 661.23 ± 33.19
∑
HBCD (g/g) 0.001 ± 0.0002 0.020 ± 0.006 7.15 ± 1.96 22.11 ± 6.03
%
∑
PBDE nominal dose NA 88.87 101.13 91.11
Number of samples 24 18 18 18
Values are expressed as mean ± SEM.
 respe
r
a
m
b
p
a
2
t
o
a
T
f
2
D
t
t
w
u
(
u
f
3
3
ia PBDE limits of detection ranged from 0.03 ng g−1 to 6.5 ng g−1 (PBDE 15 and 209,
espectively).
 water bath (50 ◦C) for 5 min, skinned, and cervical and dorsal
uscles were gently removed. Fetuses were placed in the alcian
lue/alizarin red stain solution for 24 h at 37 ◦C, followed by 1%
otassium hydroxide for 48 h, with fresh 1% potassium hydroxide
dded at 24 h, and then 0.5% potassium hydroxide for an additional
4 h. The potassium hydroxide was then replaced with a 2:2:1 solu-
ion consisting of two parts 70% ethanol, two parts glycerine, and
ne part benzyl alcohol. After 24 h, stained skeletons were placed in
 1:1 solution (70% ethanol:glycerine) for evaluation and storage.
he skull, sternebrae, vertebrae, ribs, pectoral and pelvic girdles,
ore and hind limbs and paws were examined.
.8. Statistical analyses
Data were analyzed by one-way ANOVA followed by post hoc
unnett’s test to compare means to control. When tests for assump-
ions of homogeneity of variance and normality failed, data were log
ransformed and retested. When homoscedasticity and normality
ere still not satisﬁed after this transformation, data were retested
sing Kruskal–Wallis (K–W) ANOVA on ranks. Analyses of external
n = litter) and skeletal (n = fetus) malformations were conducted
sing a 1-tail Chi-Square test to compare the proportions of affected
etuses. The level of signiﬁcance was p < 0.05.
. Results.1. BFR contents of the diets
Low levels of BDE-28, -47, -99, -100, -153 and -154 and the HBCD
somers were found in the control diet (Table 1). The relative levelsctively) and HBCD limits of detection ranged from 8.9 to 9.1 ng g−1 (- and -HBCD,
of BDE-47, -99, -100, -153, -154, and -209 did not differ across the
experimental groups; they were determined to be approximately
15%, 19%, 5%, 1.6% 1.7% and 57%, respectively, of the total mixture
and were consistent throughout the experimental period. These
congeners accounted for 99% of the PBDEs measured in the dietary
mixture. Values of total PBDE were 88–101% of the nominal doses
(Table 1).
3.2. Diet consumption during treatment
Ingestion of the BFR mixture during the exposure period did
not alter dam food consumption or weight gain (Table 2). Since the
BFR dietary mixture remained constant, there was a decrease in the
average BFR dose ingested with increased weight gain during ges-
tation (Table 2). Thus, BFR ingestion was  calculated to be on average
0.05, 17.4 and 47.5 mg  BFR/kg/day or 74–86% of target doses for the
three experimental conditions.
3.3. Effects of BFR exposure on dams
Dam survival and appearance were not affected by ingestion
of the BFR mixture. BFR exposure did not affect absolute tissue
weights (Supplementary data Table S1); however, it did result in
a signiﬁcant increase in relative liver and kidney weights at the
highest dose compared to controls (Table 3). Analysis of variance
showed a signiﬁcant effect of BFR exposure on serum T4 levels
(p = 0.047) although post hoc tests did not indicate a signiﬁcant dif-
ference from controls (Table 4). No signiﬁcant differences in the
inner thyroid epithelial follicle height were observed among the
treatment groups (control: 7.9 ± 0.4 m; low dose: 7.1 ± 0.2 m;
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Table 2
Consumption of the BFR diet during gestation.
Parameter Gestational day Nominal BFR mixture dose (mg/kg/day)
Control (0) 0.06a 20 60
Food consumption (g/day)
0–3 24.25 ± 0.81 (13) 22.91 ± 0.84 (19) 25.32 ± 0.96 (14) 23.32 ± 0.69 (17)
3–8  27.63 ± 0.96 (13) 25.53 ± 1.04 (18) 27.95 ± 1.22 (14) 28.69 ± 1.26 (16)
8–13 27.70 ± 1.16 (14) 27.76 ± 0.84 (22) 28.23 ± 0.84 (17) 25.82 ± 1.18 (17)
13–16 26.27 ± 0.97 (13) 25.77 ± 1.00 (17) 24.29 ± 0.60 (13) 25.81 ± 0.89 (13)
16–20 25.48 ± 1.11 (16) 25.09 ± 1.05 (22) 24.03 ± 0.76 (15) 24.33 ± 0.88 (17)
Gestational weight (g)
3 332.31 ± 5.10 (14) 330.37 ± 5.83 (19) 333.95 ± 7.57 (14) 320.73 ± 6.38 (16)
8  358.50 ± 5.46 (14) 350.13 ± 5.87 (21) 354.06 ± 7.77 (16) 341.12 ± 6.89 (17)
13  390.70 ± 5.88 (13) 383.55 ± 5.95 (19) 382.30 ± 8.33 (15) 370.55 ± 9.17 (15)
16  413.77 ± 5.10 (16) 402.80 ± 6.40 (20) 399.49 ± 8.85 (12) 391.19 ± 8.14 (16)
20  462.41 ± 7.51 (16) 447.43 ± 7.16 (21) 446.74 ± 7.49 (17) 441.81 ± 8.72 (17)
Approximate BFR dose (mg  BFR/kg BW)
3 0 0.046 19.17 49.68
8  0 0.049 19.96 57.47
13  0 0.048 18.67 47.62
16  0 0.043 15.37 45.08
20  0 0.037 13.60 37.64
Values are expressed as mean ± SEM of (n) observations per treatment.
a The maximum measured content of house dust PBDEs is 192 g per g dust in the studies that we  chose as a basis for our BFR mixture (Allen et al., 2008). This represents
a  dose of 1.16 g PBDE per kg/day if a toddler (16.5 kg) ingests 100 mg  dust. When we apply allometric scaling (×6.9) to adjust for the difference in body weight to surface
area  between humans and rats, our calculated rat equivalent to human dose is 8.0 g/kg/day. Thus, our low dose group represents an exposure that is approximately 5 times
the  estimated high exposure for toddlers.
Table 3
Effects of BFR exposure on dam organ weights.
Organ Nominal BFR mixture treatment dose (mg/kg/day)
Control (0) 0.06 20 60
n 15 21 17 17
Liver  34.2 ± 0.9 33.5 ± 0.7 35.3 ± 0.8 37.9 ± 0.7**
Kidney 2.15 ± 0.04 2.23 ± 0.04 2.30 ± 0.05 2.34 ± 0.04*
Spleen 1.41 ± 0.06 1.44 ± 0.05 1.47 ± 0.08 1.43 ± 0.04
Thymus  0.83 ± 0.05 0.72 ± 0.03 0.73 ± 0.04 0.79 ± 0.05
Heart  2.71 ± 0.06 2.69 ± 0.03 2.64 ± 0.04 2.66 ± 0.04
Lung  2.71 ± 0.08 2.66 ± 0.04 2.82 ± 0.07 2.77 ± 0.10
V EM.
m
s
a
g
t
s
T
E
nalues are expressed as mean tissue weight (g) normalized to body weight (kg) ± S
* p < 0.05 compared with control.
** p < 0.01 compared with control.
iddle dose: 8.1 ± 0.3 m;  high dose: 9.0 ± 0.4 m).  BFR expo-
ure also had minimal effects on the other serum parameters
ssessed in the dams (Table 4). In the high dose BFR treatment
roup total protein levels were signiﬁcantly reduced compared
o controls. Although ANOVA indicated an inﬂuence of BFR expo-
ure on phosphorus (p = 0.029), total cholesterol (p = 0.012), and
able 4
ffects of BFR exposure on dam serum biochemistry.
Parameter Nominal BFR mixture dose (mg/kg/day)
Control (0) 0.06
n 14 21 
Thyroxin (T4) (g/dL) 1.52 ± 0.12 1.59
Calcium (mg/dL) 12.38 ± 0.24 12.0
Magnesium (mg/dL) 3.23 ± 0.07 3.19
Phosphorus (mg/dL) 10.40 ± 0.45 10.2
Blood  urea N (mg/dL) 15.3 ± 0.7 14.6
Uric  acid (mg/dL) 3.49 ± 0.27 2.91
Albumin (g/dL) 2.78 ± 0.04 2.72
Total  protein (g/dL) 6.52 ± 0.11 6.49
Creatinine kinase (U/L) 311 ± 33 319
Creatinine (mg/dL) 0.53 ± 0.02 0.50
Triglycerides (mg/dL) 446 ± 52 463
Cholesterol (mg/dL) 102 ± 4 92 ±
Glucose (mg/dL) 125 ± 6 119
ALP  (U/L) 89.2 ± 14.1 83.7
ALT  (U/L) 66.0 ± 3.2 61.3
 = no. of dams. Values are expressed as mean ± SEM.
* p < 0.05 compared with control.triglycerides (p = 0.017), post hoc tests failed to reveal signiﬁcant
differences from controls. Neither estrous cycle length nor fer-
tility measures were affected by BFR exposure (Table 5). Finally,
BFR treatment did not affect the mean numbers of implanta-
tion and resorption sites, postimplantation loss, or the litter
size.
 20 60
17 17
 ± 0.09 1.68 ± 0.13 1.30 ± 0.08
6 ± 0.21 11.92 ± 0.17 12.07 ± 0.22
 ± 0.07 3.25 ± 0.06 3.07 ± 0.07
1 ± 0.63 8.84 ± 0.26 9.04 ± 0.20
 ± 0.5 13.5 ± 0.6 14.1 ± 0.4
 ± 0.21 3.18 ± 0.15 2.98 ± 0.20
 ± 0.04 2.77 ± 0.05 2.72 ± 0.07
 ± 0.19 6.21 ± 0.11 5.97 ± 0.15*
 ± 42 354 ± 35 308 ± 31
 ± 0.02 0.52 ± 0.01 0.52 ± 0.01
 ± 55 329 ± 34 292 ± 17
 3 95 ± 3 109 ± 4
 ± 6 123 ± 3 114 ± 5
 ± 9.1 111.4 ± 18.1 94.8 ± 10.5
 ± 3.0 56.0 ± 2.5 63.5 ± 3.3
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Table  5
Effects of BFR exposures on measures of dam fertility.
Parameter Nominal BFR mixture dose (mg/kg/day)
Control (0) 0.06 20 60
Estrous cycle length – days 4.8 ± 0.4 (31) 4.6 ± 0.3 (29) 4.7 ± 0.2 (29) 5.6 ± 0.6 (29)
Mating indexa 70.4 (27) 85.2 (27) 75.0 (24) 70.8 (24)
Fecundity indexb 79.0 (15) 91.3 (21) 94.4 (17) 100.0 (17)
No.  of implants per litter 17.9 ± 0.4 (15) 18.4 ± 0.4 (21) 18.4 ± 0.9 (17) 17.7 ± 0.7 (17)
No.  of resorptions per litter 0.9 ± 0.4 (15) 1.0 ± 0.3 (21) 1.5 ± 0.4 (17) 1.1 ± 0.3 (17)
Postimplantation lossesc 4.8 ± 1.8 (15) 5.4 ± 1.5 (21) 8.2 ± 1.6 (17) 6.8 ± 3.0 (17)
No.  of dead fetuses per litter 0 (15) 0.05 ± 0.05 (21) 0.06 ± 0.06 (17) 0 (17)
No.  of live fetuses per litter 17.0 ± 0.3 (15) 17.4 ± 0.4 (21) 16.8 ± 0.80 (17) 16.7 ± 0.9 (17)
Values are expressed as mean ± SEM with the total number of observations.
a Mating index = (no. of sperm positive females/no. of mated females) × 100.
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.4. Fetal developmental measures
BFR exposure had no effect on placental weights (Table 6).
etal body weights were not affected, although a signiﬁcant
ecrease in crown rump length in female fetuses was observed
n the 20 mg/kg/day BFR treatment group. Neither sex ratios nor
he anogenital distance indices in male and female fetuses were
ffected.
External fetal examinations revealed malpositioned, fused and
pread digits, crooked paws and single observations of paw edema
control fetus) and a shortened tail (60 mg/kg/day fetus) in control
nd BFR exposed fetuses (Fig. 1A–C). Fetuses with malpositioned
r fused digits were observed in 25–52% of the litters (Fig. 1D).
nalysis of the proportion of litters with fetuses with malpositioned
r fused digits revealed a signiﬁcant increase above control only in
he low dose treatment group (Fig. 1D). Among BFR exposed fetuses,
0–84% of digit defects were found in the hind paws, compared to
7% in control fetuses (data not shown).
A number of skeletal variations, including offset ossiﬁcation of
ternebrae, unossiﬁed sternebrae and vertebrae, and incompletely
used ossiﬁed centrums, were observed (Fig. 2A–D). A signiﬁcant
ncrease in the incidence of fetuses with any skeletal variation
as found in both the middle (p = 0.018) and high (p = 0.024) doses
Fig. 2E). The mean numbers of affected fetuses per litter did not dif-
er between control and treated groups; however, affected fetuses
ere found in multiple litters (Supplementary data, Fig. S1A). A
ecrease or lack of ossiﬁcation in the sternebrae was  the most sensi-
ive skeletal variation observed after BFR exposure; the incidence of
etuses with unossiﬁed sternebrae was signiﬁcantly increased in all
FR treatment groups (Table 7, Supplementary data, Fig. S1B). There
ere no signiﬁcant changes in ossiﬁcation or cartilage development
n other areas of the skeleton, including the skull, phalanges, carpals
r metacarpals. Skeletal analysis of the paws revealed no signiﬁcant
hanges in ossiﬁcation or cartilage development (Supplementary
ata, Fig. S2).
Supplementary Figs. SI and SII related to this article found, in
he online version, at http://dx.doi.org/10.1016/j.tox.2014.03.005.
. Discussion
The current study demonstrated that exposure during preg-
ancy to environmentally relevant complex BFR mixture, with
elative congener levels similar to those found in household dust,
igniﬁcantly affected fetal development. This is the ﬁrst inves-
igation to report that exposure to BFRs increased fetal digit
alformations. In addition, these data are the ﬁrst to demon-
trate an increase in the incidence of fetal skeletal variations in the
bsence of any indications of maternal toxicity following exposure
o an environmentally relevant BFR dose (0.06 mg/kg/day).0.
Effects on any parameter of maternal health were observed only
in dams exposed to the high BFR dose (60 mg/kg/day); these dams
had signiﬁcant liver and kidney enlargement and a reduction in
serum protein compared to controls. Increases in liver and kid-
ney weights are indicative of toxicity; however, there were no
changes in serum biomarkers that are typically associated with liver
and kidney damage. Our ﬁndings are consistent with a previous
investigation in which increased liver weight and drug metabo-
lizing enzyme activity were observed in GD 20 dams following
exposure to DE-71 (30 mg/kg/day) (Zhou et al., 2002). Adult males
fed the same complex BFR mixture used here showed an increase
in both liver and kidney weights following exposure to BFRs at
20 mg/kg/day (Ernest et al., 2012). Others have also reported that
exposures to PBDE congeners, as well as HBCD, are associated with
increased kidney (van der Ven et al., 2006) and liver (Ema  et al.,
2008; Stoker et al., 2004; van der Ven et al., 2006, 2008) weights.
We report here that exposure of female rats prior to conception
and during gestation (for approximately 35 days) to 60 mg/kg/day
of our BFR mixture did not affect either serum thyroxin (T4) con-
centrations or thyroid epithelial cell height in the dams. In contrast,
exposure of adult males to this BFR mixture (20 mg/kg/day for 70
days) induced a signiﬁcant decrease in serum T4 levels (Ernest et al.,
2012). Serum T4 concentrations in the male rats, independently of
exposure to BFRs, were approximately ﬁve times higher than those
in the pregnant female rats. This observation is consistent with pre-
vious studies showing a signiﬁcant reduction of thyroid hormone
levels in pregnant rats near term (Calvo et al., 1990). A number
of in vivo rodent studies have reported a decrease in serum T4
concentrations after exposure to BFRs, with results varying depend-
ing on the speciﬁc BFRs, dose, length of exposure and gender or
strain of animals studied (reviewed by Legler, 2008). With respect
to the effects of BFR exposures during pregnancy on thyroid hor-
mone status, the exposure of Sprague-Dawley rats to DE-71 (60
or 120 mg/kg/day) from gestation day 6 to 19 lowered plasma T4
concentrations on gestation day 20 (Ellis-Hutchings et al., 2009),
while exposure to DE-71, at a dose of 60 g/kg/day, from gestation
day 1.5 to lactation day 20 had no effect on serum T4 or T3 in the
dams (Blake et al., 2011). Positive associations between TSH and
the serum concentrations of lower-brominated PBDE congeners
and OH-PBDEs were reported in second trimester pregnant women
from California; however, the associations with free and total T4
were generally weak, inconsistent, and not statistically signiﬁcant
in this study (Zota et al., 2011). The lack of an effect of BFR exposure
on serum T4 concentrations or thyroid gland histomorphology in
this study suggests that the effects we  observed are not ascribed to
this mechanism.
The majority of the anomalies observed in BFR-exposed fetuses
consisted of malpositioned or fused digits in the hind paws. To the
best of our knowledge, no previous investigation has observed a
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Table 6
Effects of BFR exposure on fetal developmental measures on gestation day 20.
Parameter Sex BFR mixture dose (mg/kg/day)
0 0.06 20 60
Total number of live pups (litters) 255 (15) 365 (21) 285 (17) 283 (17)
Placental weight (mg) 477.0 ± 10.5 470.4 ± 9.57 464.6 ± 14.2 494.4 ± 21.7
Sex  ratio (M/F) 1.07 ± 0.14 1.22 ± 0.11 1.12 ± 0.17 1.18 ± 0.12
Body  weight (g)
M 3.64 ± 0.07 3.50 ± 0.05 3.45 ± 0.08 3.57 ± 0.05
F  3.39 ± 0.07 3.32 ± 0.05 3.20 ± 0.07 3.35 ± 0.05
Crown  rump length (mm)
M 36.7 ± 0.2 36.3 ± 0.2 36.0 ± 0.3 36.5 ± 0.2
F  35.7 ± 0.2 35.2 ± 0.1 34.8 ± 0.2* 35.4 ± 0.2
Anogenital distance indexa
M 139.9 ± 1.5 140.0 ± 0.9 139.1 ± 1.1 136.6 ± 1.4
F  62.1 ± 0.9 60.4 ± 0.6 61.1 ± 0.7 60.6 ± 0.8
V
× 100.
s
c
a
T
F
B
(
t
talues are expressed as mean ± SEM using the litter as the data point.
a Anogenital distance index = (anogenital distance (mm)/cubed body weight (g)) 
* p < 0.05 compared with control.imilar phenotype. One previous investigation reported a signiﬁ-
ant increase in tail malformations in the F2 generation following
 single administration of BDE-99 on GD 6 (Talsness et al., 2005).
he digit defects we observed were not associated with changes
ig. 1. Effects of gestational BFR exposure on fetal external morphology. Representative
FR/kg/body weight/day treatment group). (B) Paw with fused digits (60 mg BFR/kg/body
D)  Scatterplot depicting the numbers of fetuses with malpositioned or fused digits in in
he  control (0), 0.06, 20 and 60 mg/kg/day BFR groups, respectively. The proportion of litte
reatment group (0.06 mg/kg/day, p = 0.05; 20 mg/kg/day: p = 0.09; 60 mg/kg/day: p = 0.21in ossiﬁcation or cartilage development in the paws of exposed
fetuses, implying that only soft tissues are affected. The proportion
of litters with fetuses with malpositioned or fused digits was
signiﬁcantly increased in the low (0.06 mg/kg/day) dose treatment
 pictures of fetal hindpaws on gestation day 20. (A) Normal paw (from the 60 mg
 weight/day). (C) Paw with malpositioned digits (0.06 mg  BFR/kg body weight/day).
dividual litters; each data point represents a single litter (n = 16, 21, 17 and 18) for
rs with affected fetuses was signiﬁcantly increased only in the 0.06 mg/kg/day BFR
).
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Fig. 2. Effects of gestational BFR exposure on fetal skeletal development. Representative pictures of fetal skeletal ossiﬁcation on gestation day 20 with all six sternebrae
ossiﬁed (A, 0.06 mg BFR/kg body weight), two  sternebrae sites unossiﬁed (B, 60 mg BFR/kg body weight), offset ossiﬁcation of the sternebrae 1–4 and incomplete ossiﬁcation
of  sternebrae 5 and 6 (C, 0.06 mg  BFR/kg body weight), and an incompletely fused ossiﬁcation vertebral centrum (D, 0.06 mg BFR/kg body weight). White arrows show sites
of  typical ossiﬁcation, yellow circles mark areas with decreased or no ossiﬁcation, and red arrows show markedly offset sternebrae (C) or an incompletely fused ossiﬁcation
vertebral centrum (D). (E) Proportion of fetuses with any type of skeletal variation, including lack of ossiﬁcation of the sternebrae, markedly offset fusion of sternebrae and
incomplete or lack of ossiﬁcation of the fused vertebral centrum. (F) Proportion of fetuses with no ossiﬁcation of the sixth sternebra. Bars represent the proportion of affected
fetuses relative to the total number of fetuses examined (n = 18, 41, 26 and 38 for the control (0), 0.06, 20 and 60 doses, respectively). *p < 0.05, **p < 0.01 compared with
control. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of the article.)
Table 7
Effects of BFR exposure on fetal skeletal development.
Variation BFR mixture dose (mg/kg/day)
0 0.06 20 60
Number of fetuses examined 18 41 26 38
Two  or more unossiﬁed sternebrae 1 (5.6) 11(26.8)* 8(30.8)* 12(31.6)*
Incomplete vertebral centrum fusion 2 (11.1) 8 (19.5) 6 (23.1) 8 (21.1)
All  spinal skeletal variations 2 (11.1) 9 (22.0) 6 (23.1) 11 (29.0)
Values are the number of observed variations per group with the percentage of the total number of examined fetuses in brackets.
* p < 0.05 compared with control.
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roups. Digit defects were also observed in the 20 mg/kg/day and
0 mg/kg/day treatment groups but statistical signiﬁcance was  not
ttained.
An increase in the incidence of fetuses with skeletal variations
as observed following exposure to the BFR mixture. The most
ommon variation was a decrease in ossiﬁcation in the sternebrae,
articularly the sixth sternebra. Ossiﬁcation in the fetus is sensi-
ive to maternal toxicity (Beck, 1989); however, no indications of
oxicity were observed in dams exposed to either the low or mid-
le dose BFR regimens. In utero exposures to exogenous chemicals
uch as ethanol or tobacco smoke alter fetal skeletal ossiﬁcation;
owever, these insults are most often associated with endpoints
hat were not observed here, such as decreased fetal survival and
rowth retardation (Chernoff, 1977; Seller and Bnait, 1995).
Ossiﬁcation of the rat skeleton typically commences around GDs
5–16 and is considered an indicator of maturity. At birth typ-
cally all (95–100%) of sternebrae are ossiﬁed. Variations in the
ssiﬁcation of the sternum of rodents are relatively common, with
ncomplete ossiﬁcation one day before birth ranging from 1–7%
or sternebrae 1–4 and 6, and up to 35% for sternebra 5 (Fritz
nd Hess, 1970). In the current investigation, the sixth sterne-
ra was unossiﬁed in 35–40% of GD20 fetuses exposed to any
FR dose, compared to 5.5% in controls. These data suggest that
xposure to BFRs may  induce a delay in ossiﬁcation. Delays in
ssiﬁcation may  also be induced by fetal hypothyroidism (Capelo
t al., 2008). Previously, single BFR congeners have been reported
o induce an increase in the incidence of variations in ossiﬁca-
ion following in utero exposure. The administration of PBDE-99
2 mg/kg/day) to Sprague-Dawley rats from GDs 6–19 increased
keletal defects, including incomplete ossiﬁcation in the skull, cau-
al vertebrae and ribs, but did not affect the ossiﬁcation of the
ternebrae (Blanco et al., 2012). An earlier investigation in rabbits
eported the delayed ossiﬁcation of sternebrae following exposure
o polybromodiphenyl oxide at a high dose (15 mg/kg/day) on GDs
–20 (Breslin et al., 1989). This report, to the best of our knowledge,
s the ﬁrst to show a signiﬁcant impact on fetal bone ossiﬁcation
ollowing exposure to an environmentally relevant BFR mixture.
ince reduced ossiﬁcation may  represent a delay in developmen-
al timing it would be useful to examine the skeletons of postnatal
ups to determine whether these effects are persistent (Carney and
immel, 2007).
The current investigation shows that BFR exposure induced
evelopmental alterations at environmentally relevant doses that
ave not been reported previously. This is also the ﬁrst investigation
o determine the effects of exposure to an environmentally relevant
omplex mixture of BFRs in an animal model. Previous experiments
ave shown that mixtures of endocrine disrupting chemicals may
roduce effects that are not observed when the components are
dministered individually (reviewed by Kortenkamp, 2007). For
nstance, exposure to a mixture of thyroid hormone disrupting
hemicals, including dioxins and polychlorinated biphenyls, pro-
uced effects suggesting synergistic responses and the activation
f different mechanisms than those observed when the individ-
al components were administered (Crofton et al., 2005). Since
here are low concentrations of polybrominated dibenzo--dioxins
PBDDs) and dibenzofurans (PBDFs) in the commercial BFR mix-
ures (Hanari et al., 2006), these compounds may  also contribute
o the effects observed. Measurements of BFRs in serum from preg-
ant women (Buttke et al., 2013; Woodruff et al., 2011), umbilical
ord blood (Frederiksen et al., 2010), and fetal liver and placental
issues (Doucet et al., 2009) demonstrate that humans are exposed
o multiple BFR congeners and technical mixtures throughout ges-
ation. Therefore, elucidation of the effects and potential dangers
f exposure to complex, environmentally relevant, mixtures is crit-
cal since the impact of exposure to environmentally relevant BFR
ixtures may  differ from that of individual congeners.y 320 (2014) 56–66
In conclusion, we  have shown evidence that exposure to the
mixture of BFRs commonly found in North American household
dust alters fetal development. The phenotypes observed, includ-
ing malpositioned or fused digits and delayed ossiﬁcation in the
sternebrae, have not been reported previously in investigations of
the effects of individual BFR congeners or technical mixtures. The
absence of concurrent effects on measures of toxicity and preg-
nancy maintenance in the dams suggests that exposure to a wide
range of BFR doses may  have a direct impact on fetal development.
Supplementary data
Supplementary data Table S1 presents the absolute values for
dam organ weights. Scatterplots of the incidence of skeletal vari-
ations are provided in Supplementary data Fig. S1. Images of the
skeletal staining of paws from control and BFR exposed fetuses are
shown in Supplementary data Fig. S2.
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